Arylalkylamine N-acetyltransferase (AANAT) is expressed in astrocytes and melatonin treatment maintains AANAT in the gerbil hippocampus induced by transient cerebral ischemia

Journal of the Neurological Sciences

Volumn 294, Issue 1-2, 2010, Pages 7-17

  Park, Ok Kyu ^a   Yoo, Ki Yeon ^a   Lee, Choong Hyun ^a   Choi, Jung Hoon ^a   Hwang, In Koo ^b   Park, Jun Hong ^c   Kwon, Young Guen ^d   Kim, Young Myeong ^e   Won, Moo Ho ^a  

^a Hallym University   (South Korea)

^b Research Institute of Pharmaceutical Sciences   (South Korea)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d Yonsei University   (South Korea)

^e Kangwon National University College of Medicine   (South Korea)

Author keywords

Arylalkylamine N acetyltransferase; Astrocytes; Hippocampus; Ischemia reperfusion; Melatonin

Indexed keywords

ARALKYLAMINE ACETYLTRANSFERASE; MELATONIN; MESSENGER RNA; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL PROTECTION; CONTROLLED STUDY; GERBIL; HIPPOCAMPUS; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; LOCOMOTION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; REPERFUSION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSIENT ISCHEMIC ATTACK; ANIMAL; CELL DEATH; DRUG EFFECTS; ENZYMOLOGY; HIPPOCAMPAL CA1 REGION; ISCHEMIC ATTACK, TRANSIENT; METABOLISM; MOTOR ACTIVITY; NERVE CELL; TIME;

ANIMALS; ARYLALKYLAMINE N-ACETYLTRANSFERASE; ASTROCYTES; CA1 REGION, HIPPOCAMPAL; CELL DEATH; GERBILLINAE; GLIAL FIBRILLARY ACIDIC PROTEIN; ISCHEMIC ATTACK, TRANSIENT; MELATONIN; MOTOR ACTIVITY; NEURONS; NEUROPROTECTIVE AGENTS; PYRAMIDAL CELLS; REPERFUSION INJURY; RNA, MESSENGER; TIME FACTORS;

EID: 77953288804     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.04.013     Document Type: Article

References (47)

1. Horiguchi T., Shima H., Suga S., Ogino M., Shimizu K., Toya S., et al. Transient forebrain ischemia induces expression of serine/threonine protein phosphatase 1 mRNA in the vulnerable regions of gerbil brain. Neurosci Lett 325 (2002) 115-118
2. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239 (1982) 57-69
3. Candelario-Jalil E., Mhadu N.H., Al-Dalain S.M., Martinez G., and León O.S. Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci Res 41 (2001) 233-241
4. Glantz L., Avramovich A., Trembovler V., Gurvitz V., Kohen R., Eidelman L.A., et al. Ischemic preconditioning increases antioxidants in the brain and peripheral organs after cerebral ischemia. Exp Neurol 192 (2005) 117-124
5. Ohtaki H., Takeda T., Dohi K., Yofu S., Nakamachi T., Satoh K., et al. Increased mitochondrial DNA oxidative damage after transient middle cerebral artery occlusion in mice. Neurosci Res 58 (2007) 349-355
6. Rastogi L., Godbole M.M., Ray M., Rathore P., Pradhan S., Gupta S.K., et al. Reduction in oxidative stress and cell death explains hypothyroidism induced neuroprotection subsequent to ischemia/reperfusion insult. Exp Neurol 200 (2006) 290-300
7. Tomizawa S., Imai H., Tsukada S., Simizu T., Honda F., Nakamura M., et al. The detection and quantification of highly reactive oxygen species using the novel HPF fluorescence probe in a rat model of focal cerebral ischemia. Neurosci Res 53 (2005) 304-313
8. Duan Q., Wang Z., Lu T., Chen J., and Wang X. Comparison of 6-hydroxylmelatonin or melatonin in protecting neurons against ischemia/reperfusion-mediated injury. J Pineal Res 41 (2006) 351-357
9. Reiter R., Tang L., Garcia J.J., and Muñoz-Hoyos A. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 60 (1997) 2255-2271
10. Skaper S.D., Floreani M., Ceccon M., Facci L., and Giusti P. Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. Ann N Y Acad Sci 890 (1999) 107-118
11. Martin M., Macias M., Escames G., Leon J., and Acuña-Castroviejo D. Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB J 14 (2000) 1677-1679
12. Ganguly S., Coon S.L., and Klein D.C. Control of melatonin synthesis in the mammalian pineal gland: the critical role of serotonin acetylation. Cell Tissue Res 309 (2002) 127-137
13. Namboodiri M.A., Dubbels R., and Klein D.C. Arylalkylamine N-acetyltransferase from mammalian pineal gland. Methods Enzymol 142 (1987) 583-590
14. Sugden D., Cena V., and Klein D.C. Hydroxyindole O-methyltransferase. Methods Enzymol 142 (1987) 590-596
15. Psarakis S., Pulido O.M., Brown G.M., Grota L.J., and Smith G.K. Identification and quantification of n-acetylserotonin (NAS) in the developing hippocampus of the rat. Prog Neuropsychopharmacol Biol Psychiatry 6 (1982) 439-442
16. Hintermann E., Grieder N.C., Amherd R., Brodbeck D., and Meyer U.A. Cloning of an arylalkylamine N-acetyltransferase (aaNAT1) from Drosophila melanogaster expressed in the nervous system and the gut. Proc Natl Acad Sci U S A 93 (1996) 12315-12320
17. Chae H.D., Park T.J., Lee Y.K., Lee T.G., and Kim K.T. Rapid and simple measurement of serotonin N-acetyltransferase activity by liquid biphasic diffusion assay. Neurochem Int 35 (1999) 447-451
18. Gaudet S., Palkovits M., and Namboodiri M.A. Regional distribution of arylamine and arylalkylamine N-acetyltransferase activities in the rat brain. Brain Res 539 (1991) 355-357
19. Paul S.M., Hsu L.L., and Mandell A.J. Extrapineal N-acetyltransferase activity in rat brain. Life Sci 15 (1974) 2135-2143
20. Uz T., and Manev H. Chronic fluoxetine administration increases the serotonin N-acetyltransferase messenger RNA content in rat hippocampus. Biol Psychiatry 45 (1999) 175-179
21. Uz T., and Manev H. Prolonged swim-test immobility of serotonin N-acetyltransferase (AANAT)-mutant mice. J Pineal Res 30 (2001) 166-170
22. Uz T., Qu T., Sugaya K., and Manev H. Neuronal expression of arylalkylamine N-acetyltransferase (AANAT) mRNA in the rat brain. Neurosci Res 42 (2002) 309-316
23. Tanaka D., Furusawa K., Kameyama K., Okamoto H., and Doi M. Melatonin signaling regulates locomotion behavior and homeostatic states through distinct receptor pathways in Caenorhabditis elegans. Neuropharmacology 53 (2007) 157-168
24. Baydas G., and Tuzcu M. Protective effects of melatonin against ethanol-induced reactive gliosis in hippocampus and cortex of young and aged rats. Exp Neurol 194 (2005) 175-181
25. Benitez-King G., Tunez I., Bellon A., Ortiz G.G., and Anton-Tay F. Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells. Exp Neurol 182 (2003) 151-159
26. Cruz A., Túnez I., Martínez R., Muñoz-Castañeda J.R., Ramírez L.M., Recio M., et al. Melatonin prevents brain oxidative stress induced by obstructive jaundice in rats. J Neurosci Res 85 (2007) 3652-3656
27. Leipnitz G., Seminotti B., Haubrich J., Dalcin M.B., Dalcin K.B., Solano A., et al. Evidence that 3-hydroxy-3-methylglutaric acid promotes lipid and protein oxidative damage and reduces the nonenzymatic antioxidant defenses in rat cerebral cortex. J Neurosci Res 86 (2008) 683-693
28. Martinez-Cruz F., Pozo D., Osuna C., Espinar A., Marchante C., and Guerrero J.M. Oxidative stress induced by phenylketonuria in the rat: prevention by melatonin, vitamin E, and vitamin C. J Neurosci Res 69 (2002) 550-558
29. Rennie K., de Butte M., Fréchette M., and Pappas B.A. Chronic and acute melatonin effects in gerbil global forebrain ischemia: long-term neural and behavioral outcome. J Pineal Res 44 (2008) 149-156
30. Joo J.Y., Uz T., and Manev H. Opposite effects of pinealectomy and melatonin administration on brain damage following cerebral focal ischemia in rat. Restor Neurol Neurosci 13 (1998) 185-191
31. Kilic E., Ozdemir Y.G., Bolay H., Keleştimur H., and Dalkara T. Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J Cereb Blood Flow Metab 19 (1999) 511-516
32. El-Sherif Y., Tesoriero J., Hogan M.V., and Wieraszko A. Melatonin regulates neuronal plasticity in the hippocampus. J Neurosci Res 72 (2003) 454-460
33. Hwang I.K., Yoo K.Y., An S.J., Li H., Lee C.H., Choi J.H., et al. Late expression of Na+/H + exchanger 1 (NHE1) and neuroprotective effects of NHE inhibitor in the gerbil hippocampal CA1 region induced by transient ischemia. Exp Neurol 212 (2008) 314-323
34. Kim D.H., Li H., Yoo K.Y., Lee B.H., Hwang I.K., and Won M.H. Effects of fluoxetine on ischemic cells and expressions in BDNF and some antioxidants in the gerbil hippocampal CA1 region induced by transient ischemia. Exp Neurol 204 (2007) 748-758
35. Loskota W.A., Lomax P., and Verity M.A. A Stereotaxic Atlas of the Mongolian Gerbil Brain (Meriones unguiculatus) (1974), Ann Arbor Science Publishers Inc, Michigan
36. Hwang I.K., Yoo K.Y., Kim D.W., Choi J.H., Lee I.S., and Won M.H. Hyperoxidized peroxiredoxins and glyceraldehyde-3-phosphate dehydrogenase immunoreactivity and protein levels are changed in the gerbil hippocampal CA1 region after transient forebrain ischemia. Neurochem Res 32 (2007) 1530-1538
37. Hwang I.K., Yoo K.Y., Li H., Lee B.H., Suh H.W., Kwon Y.G., et al. Aquaporin 9 changes in pyramidal cells before and is expressed in astrocytes after delayed neuronal death in the ischemic hippocampal CA1 region of the gerbil. J Neurosci Res 85 (2007) 2470-2479
38. Hwang I.K., Yoo K.Y., Suh H.W., Kim Y.S., Kwon D.Y., Kwon Y.G., et al. Folic acid deficiency increases delayed neuronal death, DNA damage, platelet endothelial cell adhesion molecule-1 immunoreactivity, and gliosis in the hippocampus after transient cerebral ischemia. J Neurosci Res 86 (2008) 2003-2015
39. Carney J.M. Acute tryptophan pretreatment protects against behavioral changes caused by cerebral ischemia. Neurosci Lett 66 (1986) 127-130
40. Janać B., Radenović L., Selaković V., and Prolić Z. Time course of motor behavior changes in Mongolian gerbils submitted to different durations of cerebral ischemia. Behav Brain Res 175 (2006) 362-373
41. Cho S., Joh T.H., Baik H.H., Dibinis C., and Volpe B.T. Melatonin administration protects CA1 hippocampal neurons after transient forebrain ischemia in rats. Brain Res 755 (1997) 335-338
42. Cuzzocrea S., Costantino G., Gitto E., Mazzon E., Fulia F., Serraino I., et al. Protective effects of melatonin in ischemic brain injury. J Pineal Res 29 (2000) 217-227
43. González-Burgos I., Letechipíá-Vallejo G., López-Loeza E., Morali G., and Cervantes M. Long-term study of dendritic spines from hippocampal CA1 pyramidal cells, after neuroprotective melatonin treatment following global cerebral ischemia in rats. Neurosci Lett 423 (2007) 162-166
44. Letechipia-Vallejo G., López-Loeza E., Espinoza-González V., Gonzalez-Burgos I., Olvera-Cortés M.E., Moralí G., et al. Long-term morphological and functional evaluation of the neuroprotective effects of post-ischemic treatment with melatonin in rats. J Pineal Res 42 (2007) 138-146
45. Roseboom P.H., Coon S.L., Baler R., McCune S.K., Weller J.L., and Klein D.C. Melatonin synthesis: analysis of the more than 150-fold nocturnal increase in serotonin N-acetyltransferase messenger ribonucleic acid in the rat pineal gland. Endocrinology 137 (1996) 3033-3045
46. Pei Z., and Cheung R.T. Melatonin protects SHSY5Y neuronal cells but not cultured astrocytes from ischemia due to oxygen and glucose deprivation. J Pineal Res 34 (2003) 194-201
47. Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res 44 (2008) 26-40